ZBNA
MDGL icon

Zions Bancorporation, National Association’s Madrigal Pharmaceuticals MDGL Stock Holding History

Zions Bancorporation, National Association’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Buy
27
+20
+286% +$10.2K ﹤0.01% 839
2026
Q1 		$3.66K Buy
7
+2
+40% +$956 ﹤0.01% 1070
2025
Q4 		$2.91K Buy
+5
New +$2.55K ﹤0.01% 937

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zions Bancorporation, National Association's MDGL Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Madrigal Pharmaceuticals (MDGL) stake by 286% in Q2 2026, buying an estimated $10.2K and bringing the position to 27 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #839.

Zions Bancorporation, National Association first reported a position in MDGL in Q4 2025 and has held it in 3 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Zions Bancorporation, National Association held 27 shares of Madrigal Pharmaceuticals worth $14.5K as of Q2 2026.
  • Zions Bancorporation, National Association bought 20 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #839 holding.
  • Zions Bancorporation, National Association first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.